ABANDONED - AFTER INTER-PARTES DECISION
after inter
on 10 Dec 2024
Last Applicant/ Owned by
800 Bridge Pkwy
Redwood City
CA
94065
Serial Number
88861317 filed on 06th Apr 2020
Registration Number
N/A
Correspondent Address
AARON D. HENDELMAN
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
SPARX PROTEIN
Pharmaceutical preparations for targeting tissues based on select tissue markers and ligands for use in cancer treatment and immunotherapy; pharmaceutical preparations for the purpose of binding ligands using engineered polypeptides and receptors for use in cancer treatment and immunotherapy; none of the foregoing for gene therapy or for the diagnosis or treatment of genetic, retinal, or hematolog Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for targeting tissues based on select tissue markers and ligands for use in cancer treatment and immunotherapy; pharmaceutical preparations for the purpose of binding ligands using engineered polypeptides and receptors for use in cancer treatment and immunotherapy; none of the foregoing for gene therapy or for the diagnosis or treatment of genetic, retinal, or hematologic diseases and disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 88861317
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 48104-TM1006
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 10th Dec 2024 | ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION |
| 10th Dec 2024 | OPPOSITION TERMINATED NO. 999999 |
| 10th Dec 2024 | ABANDONMENT - AFTER INTER PARTES DECISION |
| 10th Dec 2024 | OPPOSITION DISMISSED NO. 999999 |
| 13th Oct 2024 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| 11th Oct 2024 | OPPOSITION INSTITUTED NO. 999999 |
| 14th May 2024 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| 16th Apr 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 16th Apr 2024 | PUBLISHED FOR OPPOSITION |
| 27th Mar 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |